BriaCell Therapeutics
-
BriaCell Therapeutics Raises $8.5M After Positive Results for Experimental Cancer Therapy
BriaCell Therapeutics recently closed an $8.5 million stock sale after its positive results from mid-stage testing of its experimental metastatic breast cancer therapy, writes John…
Founding Partners
Advertisement
Affiliate Partners
